-
Oxford BioDynamics signs fifth collaboration agreement in immuno-oncology space
The company will use its EpiSwitch platform to offer high resolution mapping of epigenetic profiles in patients
2018-11-16 16:39 -
PCI Pharma Services celebrates the installation of its 80th Seriali
PCI extends industry leading position for product security for global medicines with significant serialisation and anticounterfeiting technology inves...
2018-11-16 16:36 -
£500,000 grant could lead to a new class of antibiotics to combat superbugs
A new antibiotic, hailed as the “last line of defence” in the battle against drug-resistant superbugs such as MSRA and VRE, is taking the next step ...
2018-11-16 16:34 -
Suven Life Sciences secures product patents in Israel and Japan
The granted claims of the patents include the class of selective M1 PAM and 5-HT4 compounds respectively and are being developed as ther...
2018-11-16 14:00 -
Nominations & applications invited for CDRI awards in drug research development
These awards are given annually to Indian nationals below 45 years of age who are engaged in basic and applied research in the area havi...
2018-11-16 13:53 -
Local pharma formulators to benefit from new USFDA generic guidance: Report
The regulatory clarity will benefit formulators such as Lupin (inhalation, injectable and ophthalmic), Cadila Healthcare (inhalation and...
2018-11-16 13:48 -
CCI blames unreasonable trade margins for high drug prices
In the note, the regulator said various industry practices choke competition but do not violate the competition law.
2018-11-16 13:45 -
AstraZeneca sells off paediatric lung infection drug to Sobi for $1.5bn
In addition to Synagis, the deal also means that Sobi will receive 50% of all future earnings of candidate drug MEDI8897, a follow-on ca...
2018-11-14 11:13 -
Lannett Enters Into Agreement with Amneal for Levothyroxine
Lannett will continue to distribute the two other products in its distribution agreement with JSP, Butalbital, Aspirin, Caffeine with Co...
2018-11-14 10:52 -
BridgeBio Pharma Enters Genetic Disease Alliance
"We are excited to launch this new alliance with BridgeBio to bring new and innovative therapies to some of the most vulnerable patients...
2018-11-14 10:37
Hot News
- SABIC Shuts Down 865,000-Ton U... Jul 02, 2025
- ExxonMobil Launches $10 Billio... Jul 17, 2025
- The Truth Behind the US-China ... Jun 30, 2025
- Sally Beauty Acquires Flair Ha... Jul 07, 2025
- UBE Corporation Accelerates Ch... Jul 02, 2025
Related Products
Related Producers
